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Asthma is the most common chronic disease of childhood and affects nearly 5 million children.
The prevalence and severity of childhood asthma have continued to increase over the past
decade despite major advances in the recognition and treatment of this condition. A comparison
of urban and rural children suggests that the etiology of airway disease is multifactorial and that
unique exposures and genetic factors contribute to the development of asthma in both settings.
The most important environmental exposure that distinguishes the rural environment and is
known to cause asthma is the organic dusts. However, animal-derived proteins, common
allergens, and low concentrations of irritants also contribute to the development of airway
disease in children and adults living in rural communities. A fundamental unanswered question
regarding asthma is why only a minority of children who wheeze at an early age develop
persistent airway disease that continues throughout their life. Although genetic factors are
important in the development of asthma, recurrent airway inflammation, presumably mediated by
environmental exposures, may result in persistent airway hyperresponsiveness and the
development of chronic airway disease. Increasing evidence indicates that control of the acute
inflammatory response substantially improves airflow and reduces chronic airway remodeling.
Reducing exposure to agricultural dusts and treatment with anti-inflammatory medication is
indicated in most cases of childhood asthma. In addition, children with asthma from rural (in
comparison to urban) America face multiple barriers that adversely affect their health e.g., more
poverty, geographic barriers to health care, less health insurance, and poorer access to health
care providers. These unique problems must be considered in developing interventions that
effectively reduce the morbidity and mortality of asthma in children from rural communities. Key
words: agricultural, asthma, children, endotoxin, noxious gases, organic dusts, rural. - Environ
Health Perspect 107(suppl 3:393-401 (1999).
http.//ehpnetl.niehs.nih.gov/docs/l999/suppl-3/393-40 lschwartz/abstract.html
Scope ofthe Problem
Asthma is the most common chronic
disease of childhood and affects nearly 5
million children (1). The prevalence (2)
and severity (1-3) of childhood asthma
have continued to increase over the past
decade despite major advances in the
recognition and treatment of this condi-
tion. Since 1980, the hospitalization rate
has increased by 28% for children less than
25 years of age and the mortality has dou-
bled for children between 5 and 24 years of
age (1). Although demographic factors
such as age, race, and socioeconomic status
appear to be risk factors for the develop-
ment and progression of asthma (2,4-6),
the increasing prevalence and severity of
asthma suggest that agents in the work-
place (7) and general environment (8-12)
play a particularly important role in the eti-
ology and pathogenesis of this condition.
In rural communities, children commonly
are exposed to organic dusts, agricultural
chemicals, animal allergens, and grain dust
mites that are brought into the home on
work clothing (13). Moreover, for children
in rural settings, the farm is their home,
playground, and workplace, with children
as young as 5 years ofage participating in
farm chores (13).
Comparison ofurban and rural children
suggests that the etiology ofairway disease
is multifactorial and that unique exposures
may contribute to the development ofdis-
ease in both settings. Among children, at
least five studies have compared the preva-
lence ofairway disease in urban and rural
populations. As depicted in Table 1, two
studies (14,15) found that urban children
had a higher prevalence of asthma, two
studies reported no difference in the preva-
lence ofasthma (16) or airway hyperreac-
tivity (17), and one study (18) reported a
higher prevalence of asthma among chil-
dren living in rural communities. Because
the setting and the definition of asthma
vary from one study to the next, it is diffi-
cult to draw any clear conclusion regarding
urban/rural differences in the prevalence of
airwaydisease.
However, among adults, agricultural
workers and those living in rural environ-
ments appear to be at high risk ofdeveloping
chronic airway disease, particularly asthma
or bronchitis (19-25). The risk associated
with the development ofchronic airway
disease appears to be more than 3-fold
greater among those who are more heavily
exposed to dusts generated in the agricul-
tural environment (21). Among farmers,
15% had symptoms consistent with either
asthma or allergic rhinitis (26). Cigarette
smoking does not appear to account for this
excess risk, as farmers have relatively low
rates ofcigarette smoking (27,28). These
epidemiologic observations are supported
by an increasing number of exposure-
specific studies in agricultural workers. In
fact, airway disease is relatively common
among those exposed to cotton, flax,
hemp, grain dust, and other organic dusts
(13,29-31). Although data are lacking
regarding the prevalence ofasthma in the
rural population, absolutely no data are
available concerning the incidence of
asthma among agricultural workers and
their family members, who are often
exposed to similar bioaerosols. Agricultural
workers and those other adults living in a
rural environment encounter a variety of
inhaled organic dusts suspended in the
atmosphere, including molds and pollens in
the air, dusts generated in silos and barns,
aeroallergens, silica from the soil, and gen-
eral exposure to animal danders, grain dust,
feed additives, and mite dust (32).
Potential Causes of
Airway Disease
As seen in Table 2, the most important
environmental exposure that distinguishes
the rural environment and is known to
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cause asthma is the organic dusts. Grain
dust, cotton dust, and dusts generated in
dairy barns represent a complex mixture of
vegetable particles and fragments, micro-
organisms and their products, insects and
insect fragments, feed additives including
fish meal and antibiotics, avian and rodent
proteins, and pesticides. Several lines ofevi-
dence indicate that endotoxin is one ofthe
primary agents in organic dust that causes
airway inflammation and airflow obstruc-
tion. First, the concentration of inhaled
endotoxin in the bioaerosol is strongly asso-
ciated with the development ofacute decre-
ments in airflow among cotton workers
(33-35), swine confinement workers (36),
and poultry workers (37). The concentra-
tion ofendotoxin in the bioaerosol is the
most important occupational exposure
associated with the development (38,39)
and progression (40) ofairway disease in
agricultural workers. Second, physiologi-
cally, inhaled endotoxin (38,41-44), grain
dust (45-47), or cotton dust (34,48-50)
can cause airflow obstruction in naive or
previously unexposed subjects. Naive,
healthy study subjects challenged with dust
from animal confinement buildings
develop airflow obstruction and an increase
in the serum concentration ofneutrophils
and interleukin (IL)-6, all ofwhich are
most strongly associated with the concen-
tration of endotoxin (not dust) in the
bioaerosol (51). Finally, our previous expo-
sure-response studies have shown that
inhaled grain dust and endotoxin produce
similar physiologic and biologic effects in
humans (47,52,53) and mice (53-56); the
Table 1. Prevalence difference in airway reactivity and asthma between children from urban and rural communities.
Airway hyperreactivity(%) Asthma(%)
Location n Age (years) Urban Rural Urban Rural Source
South Africa 1,375 6-9 3.17 0.14 (14)
Australia 170 8-12 22.0 21.3 (17)
Australia 915 5-18 20.6 22.4 (16)
Kenya 1,172 8-17 9.3 2.5 (15)
Iran 400 5-11 0.5 4.5 (18)
Table2. Categories of exposure and selected agents known to cause asthma in the rural environment.
Category Occupations Causative agents
Organic dusts Grain and cotton industries, Endotoxin, tannins, plant proteins and
farmers, lumber industry pollens, mycotoxins, insect parts
Animal-derived materials Farmers, animal handlers Antigenic proteins
Irritants Farmers, pesticide manufacturers Pesticides, herbicides, fertilizers
Fumes Farmers Ammonia, oxides of nitrogen,
welding fumes
Sensitive-C3H/HeBFEJ
concentration ofendotoxin in grain dust
plays an important role in the acute bio-
logic response to grain dust in humans
(52) and mice (54,55); a competitive
antagonist for lipopolysaccharide (LPS)
(Rhodobacter spheroides diphosporyl lipid
A) reduces the inflammatory response to
inhaled grain dust in mice (56); and
genetic (Figure 1) or acquired hyporespon-
siveness to endotoxin substantially reduces
the biologic response to grain dust in mice
(54). Together, these studies indicate that
endotoxin is an important cause oforganic
dust-induced airwaydisease.
However, other components oforganic
dust mayplay a role in the development of
acute as well as chronic airway disease.
Organic dusts are composed of a complex
mixture ofvegetable particles and frag-
ments, microorganisms and their prod-
ucts, insects and insect fragments, feed
additives including fish meal and antibi-
otics, avian and rodent proteins, and pesti-
cides (57). Among farmers, longitudinal
declines in forced expiratory volume in 1
sec (FEV1) are significantly associated with
the use of quarternary ammonium com-
pounds and automated dry feeding systems
(58). Specific plant components such as
bract from grain sorghum have enhanced
chemotactic activity for neutrophils (59).
Moreover, depletion ofendotoxin from the
grain sorghum dust extract had no effect
on in vitro neutrophil chemotactic activity
or the abilityofthe extract to activate com-
plement (60). Tannins found in grain dust
(61,62) activate phospholipase C and A2,
leading to the release ofdiacyglycerol,
mobilization ofintracellular free calcium,
Resistant-C3H/HeJ
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Figure 1. Histologic sections of mouse lungs following inhalation of corn dust extract. The endotoxin-sensitive mice (C3H/HeBFEJ) demonstrate a profound neutrophilic
inflammatory response primarily localized to the conducting airway, whereas no inflammatory response is observed in the endotoxin-resistant (C3H/HeJ) mice
)hematoxylin-eosin, original magnification 1,000x).
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and contraction of smooth muscle (62).
However, the concentration ofendotoxin
in the bioaerosol is not always predictive of
respiratory symptoms among agricultural
workers (63,64). These studies suggest that
other components may be important in
the development oforganic dust-induced
airway disease.
Animal-derived proteins can cause
asthma in agricultural workers. This form
ofasthma is much more common in atopic
individuals capable of developing an IgE
response to specific aerosolized animal pro-
teins. Animal handlers, especially in sale
barns and confinement units, may be inter-
mittently exposed to high concentrations
of animal-derived proteins and are at par-
ticularly high risk of developing asthma.
Cow epithelium is one ofthe most impor-
tant inducers of occupational asthma
among farmers in Finland (65). Antigens
such as cockroach dust, common to the
urban environment, are also associated
with airway disease in the rural environ-
ment (66). Onset ofwheezing is usually
immediate and often accompanied by
rhinitis and other allergic symptoms.
Low concentrations of irritants may
result in airflow obstruction in workers
with underlying asthma but do not usually
cause asthma. Thus, chemicals common to
the agricultural environment, including
pesticides, herbicides, and fertilizers, as well
as wood smoke and alternative sources of
fuel (67), may contribute to the exacerba-
tion ofairflow obstruction in children with
asthma. Organophosphate insecticides (68)
may induce bronchospasm in exposed
individuals. These pesticides inhibit acetyl-
cholinesterase and may result in a choliner-
gic response, inducing bronchospasm and
bradycardia. Although research is lacking in
this area, the exposure-response relation-
ship is commonly reported in agricultural
workers and may represent an important
point ofintervention for childhood asthma.
Moreover, air pollutants such as ozone may
promote the development ofairway disease
among rural residents (69,70).
Reactive airways dysfunction syndrome
is an extreme form of irritant-induced
asthma that may occur following inhalation
ofhigh concentrations offumes in the agri-
cultural setting (71). In particular, noxious
gases such as ammonia and oxides ofnitro-
gen may cause acute extensive airway injury
and result in recurrent episodes ofairflow
obstruction. Characteristically, reactive
airways dysfunction syndrome occurs only
after an overwhelming exposure to irritating
gases. The individual should be able to
report a specific event where they were
exposed to a high concentration offumes
that resulted in an acute respiratory illness.
These exposures can cause acute alveolar
injury and result in pneumonia or adult res-
piratory distress syndrome. Subsequent to
the acute illness, the individual may develop
recurrent episodes ofairflow obstruction
that are caused byavarietyofirritants.
Clinical Features
Asthma is a chronic inflammatory condition
ofthe airways that results in variable and/or
intermittent airflow obstruction (72). The
objective signs of airflow obstruction are
often associated with symptoms of chest
tightness, wheezing, coughing, dyspnea, and
enhanced sputum production. For the pur-
poses ofthis article, rural exposures are con-
sidered to be relevant to the development
and progression ofchildhood asthma ifthe
asthma is first diagnosed following exposure
to agricultural dusts, agricultural allergens,
or agricultural fumes, or ifpreviously estab-
lished asthma is aggravated by exposure to
agricultural dusts, agricultural allergens, or
agricultural fumes. Diagnosing environmen-
tal asthma depends on the demonstration of
variable degrees ofairflow obstruction that
occurs in direct response to specific agents
that are aerosolized in the environment.
Because immediate and delayed (up to 12
hr) airway responses may occur after these
exposures, the specific agent causing the
onset ofairflow obstruction may not always
be obvious. Importantly, acute airway injury
caused by exposure to fumes (ammonia and
nitrogen dioxide) may result in chronic
intermittent episodes ofairflowobstruction.
The diagnosis of asthma is based on
the demonstration of reversible airflow
obstruction (72). Standard spirometry,
reversible airflow obstruction after bron-
chodilators, and inducible airflow obstruc-
tion with nonspecific airway challenges
are considered acceptable physiologic assess-
ments of reversible airflow obstruction.
Demonstration ofan FEVy to forced vital
capacity (FVC) ratio ofless than 65% is
considered diagnostic ofairflowobstruction.
A decrease in the FEV1/FVC ratio is usually
associated with a low FEV, (less than 80%
predicted or in the bottom tail ofthe 90%
confidence interval) or a low forced expira-
tory flow (FEF)25s75 (less than 60%
predicted). Variability in airflow obstruction
is usually demonstrated by sequential
spirometry but may be documented by
improvement in airflow with bronchodila-
tors (at least a 12% improvement in FEV,
is considered significant) or significant
worsening of airflow (2 20% decline in
FEVI) following inhalation of either
histamine or methacholine.
Asthma caused by rural exposures
requires the demonstration of a clear
temporal relationship to specific exposures
in the rural setting that are known to
cause asthma. Features in history that are
helpful in identifying an environmental
etiology include:
* Presence of asthma-causing agents in
the home or farm environment
* New onset asthma or worsening of
previous asthma
* Exposure to an overwhelming concen-
tration ofammoniaor oxides ofnitrogen
* Worsening ofsymptoms during times
ofmore intense exposure
* Improvement ofsymptoms when away
from home orwith seasonal changes
However, unlike occupational causes
ofasthma, the child living on the farm is
exposed every day of the week. Thus, the
temporal relationship between exposures
and symptoms may be difficult to deter-
mine. Physiologic testing, either by
spirometry, peak flow measurements, or
periodic nonspecific bronchoprovocative
challenges, can and should be used to criti-
cally evaluate the temporal relationship
between exposures and the development of
airflow obstruction. For instance, demon-
stration of consistent decreases in either
FEV, of 10% or peak flows of at least
20% when exposed to a specific agent in
the rural setting not only helps establish
the diagnosis of asthma but may assist in
identifying the offending agent. Although
peak flow measures are dependent on
patient cooperation and are less reliable
than traditional spirometric measures of
airflow, peak flow measurements are often
the only feasible approach to investigating
environmental causes of asthma. Specific
airway challenges are the most definitive
method used to make the diagnosis; how-
ever, these inhalation challenges are not
entirely accurate, and very few centers are
equipped to perform these potentially
hazardous exposure-response studies.
Pathogenesis
A fundamental unanswered question in
asthma is why do only a minority ofchil-
dren who wheeze at an early age develop
persistent airway disease that continues
throughout their lives (73). Although
wheezing in association with a lower res-
piratory infection occurs in up to 30% of
children less than 3 years of age, only
40% of these children develop persistent
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wheezing at 6 years of age (74). In a
prospective, population-based longitudi-
nal study, persistent wheezing at 6 years
of age was associated with recurrent
episodes ofwheezing, maternal history of
asthma, maternal history of cigarette
smoking, elevated serum IgE levels in the
first year of life, and diminished Vmax
functional reserve capacity at 6 years of
age (74). However, lung function in the
first year oflife was not a predictor ofper-
sistent wheezing at 6 years of age (74).
The development ofasthma after 6 years
of age was significantly associated with
mild wheezing and airway hyperrespon-
siveness at 6 years ofage (75). Moreover,
the diagnosis ofasthma at 7 years ofage is
associated with a progressive deficit in
lung function during the next 10 years
while the lung should be actively develop-
ing (76). Airway hyperresponsiveness was
also found to be associated with reduced
levels and lower rates ofincrease in FEV,
and FEF25-75 in a population ofchildren
and young adults followed for up to 12
years (77). These findings suggest that in
genetically susceptible individuals (78),
recurrent airway inflammation (not
abnormal lung function in the first year of
life), presumably mediated by environ-
mental exposures (e.g., viral infections,
allergens, cigarette smoke), results in per-
sistent airway hyperresponsiveness and the
development of abnormal airway func-
tion. Although all forms of asthma can
result in persistent disease, environmental
models ofasthma provide an ideal oppor-
tunity to investigate the biologic origin of
persistent airway hyperreactivity and
airway remodeling (73).
The pathogenesis ofasthma induced or
exacerbated by exposures in the rural set-
ting is highly variable and entirely depen-
dent on the specific nature and intensity of
the exposure. Airway narrowing caused by
inflammation, edema, or hyperreactivity
results in acute and reversible decreases in
airflow. Allergic and nonallergic mecha-
nisms ofinflammation directly injure the
airway epithelia. Recurrent episodes of
inflammation may result in chronic
remodeling ofthe conducting airways and
could be responsible for the development
ofprogressive airflow obstruction.
Classic allergic mechanisms ofairway
inflammation involving mast cells, IgE,
histamine, and eosinophils may be respon-
sible for the development ofasthma after
exposure to animal-derived proteins. In
patients with an IgE-mediated response,
the symptoms and signs of asthma occur
in temporal proximity to the exposure.
Patients can usually identify the specific
agent, and these individuals have an atopic
history. IgE-antigen interactions will
result in mast cell degranulation with the
release ofhistamine. Histamine can stimu-
late bronchial obstruction by enhancing
vascular permeability, increasing smooth
muscle contraction and mucus secretion,
and upregulating the production of
prostaglandins (79).
Several lines of evidence indicate that
the physiologic response to organic dust is
primarily mediated by an acute nonallergic
(or innate) inflammatory response in the
lower respiratory tract. First, although
atopy may play a role in selected cases of
organic dust-induced airway disease
(19,80-82), the atopic status and the pres-
ence ofspecific antibodies have not been
consistently associated with either acute
(45,83-86) or chronic (87-90) airway
responses to inhaled organic dust. Second,
in vitro studies have demonstrated that
grain dust can induce macrophages to
release neutrophil chemotactic factors (60)
and IL-i (91), and animal studies have
shown that inhaled grain dust causes a neu-
trophilic response in the lower respiratory
tract (60,92). Finally, human inhalation
MIP-2 E11 1
MIP-lcz
MlP-1lp
TGF-pl1
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studies have demonstrated that organic
dust can induce airflow obstruction in pre-
viously unexposed individuals (45-47);
grain-dust induced airflow obstruction
occurs within 30 min of exposure (45-
47,53,83-85); this airway response is
dependent on the inhaled dose ofgrain
dust (45-47,83-85); and neutrophils,
macrophages, and cytokines/chemokines
rapidly accumulate in the upper and lower
respiratory tract (46,47,93).
Macrophages and neutrophils appear
to play pivotal roles in the initial inflam-
matory response to inhaled organic dust.
In vitro, organic dust is directly chemotac-
tic for neutrophils (60) and can induce
alveolar macrophages to release IL-1 (91)
and other mediators that have potent
chemotactic activity for neutrophils (60).
Inhalation studies in humans (46,47,52,
53,93) and mice (53-55) have shown that
following a single exposure to grain dust,
neutrophils are rapidly recruited to the
lung, and proinflammatory cytokines (IL-
1p, tumor necrosis factor (TNF)-ca, and
IL-6), chemokines [IL-8 and macrophage
inflammatory protein-2 (MIP-2)], and
growth factors are produced and released
for up to 48 hr (Figure 2) (53). Immuno-
histochemical staining (94) and in situ
..muuu.......... iuum um...v...
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Figure 2. RNase protection assay of total RNA obtained from mouse lungs after inhalation of CDE, LPS, or SAL.
Abbreviations: CDE, corn dust extract; IFN, interferon; IL, interleukin; LPS, lipopolysaccharide; MIP, macrophage
inflammatory protein; SAL, saline; TGF, transforming growth factor; TNF, tumor necrosis factor. Equivalent
amounts of RNAwere examined in each sample, as evaluated bythe amount of L32, which encodes a ubiquitously
expressed ribosome subunit protein.
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hybridization (95) indicate that the
macrophage and the neutrophil are actively
involved in the de novo synthesis ofthese
proinflammatory agents. The influx of
neutrophils can be partially inhibited by
prior treatment with TNF-a-specific
antibodies (96).
Epithelial cells may also be involved in
recruitment and modulation ofthe inflam-
matory response to inhaled organic dust.
Epithelial cells (A549 and bronchial
epithelia) require a specific host-derived
signal (TNF-a or IL-1) for induction of
IL-8 (97-101). In a baboon model ofsep-
sis, pretreatment with anti-TNF-a anti-
body significantly reduced the circulating
concentration of IL-8 (102), suggesting
that TNF-a and/or IL-1 are needed to
stimulate other cells to release IL-8 and
promote neutrophil chemotaxis. MIP-2 is
thought to be the murine homologue of
IL-8 (98,103), has potent chemotactic
activity for neutrophils (104), is a member
ofthe IL-8 supergene family (98), has sig-
nificant peptide sequence homology with
IL-8 (98), and is upregulated in rat lungs
following intraperitoneal endotoxin chal-
lenge (103). We have found that human
IL-8 (Figure 3) (94) and MIP-2 (95) are
produced and released by airway epithelia
following an inhalation challenge with
grain dust, suggesting that airway epithelia
are activated either directly by grain dust
or by cells or cell products that come in
contact with the apical or basolateral por-
tion ofthese cells. In aggregate, these find-
ings suggest that inhaled grain dust
initiates a complex interaction between
inflammatory (primarily macrophages and
neutrophils) and structural (airway epithe-
lial) cells, and that this interaction is medi-
ated by specific proinflammatory cytokines
and chemokines that are produced and
released in the airway lumen and possibly
the interstitium ofthe lung.
Noxious gases and irritants may directly
injure the airway epithelia, resulting in
edema, inflammation, and cell death. In
fact, the airwayepithelia may prove to be an
important mediator of the inflammatory
response by producing and releasing chemo-
tactic factors such as IL-8 (98). Sloughing
ofthe airway epithelia and thickening ofthe
subepithelial region is common in asthma
and has been reported in asthma associated
with agricultural exposures (105). Thus, the
airway epithelia may actually contribute to
the edema and inflammation following
inhalation ofparticularlyirritatingstimuli.
There is mounting evidence that
asthma involves a fibrotic response that
alters the structure and function ofthe air-
way. Although thickening and fibrosis of
the subepithelial region beneath the base-
ment membrane is a consistent (106-110)
histologic feature ofasthma directly related
to the clinical severity of this disease
(111,112), the biologic factors that cause
this localized fibrotic response have not
been well defined. Immunohistochemical
staining indicates that the subepithelial
fibrosis consists predominantly of types I,
III, and IV collagen, which probably origi-
nate from fibroblasts and myofibroblasts
(108,113), rather than epithelial cells
(which produce branched collagens, types
V and VII) (114). However, recent studies
have shown that transforming growth
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Figure 3. Reverse transcriptase-polymerase chain reaction gel and densitometry ofairway epithelia mRNAfor IL-6,
[l-8, and TNF-a 4 hr after inhalation challenge in humans with corn dust extract or saline. Abbreviations: C, corn
dustextract; IL, interleukin; S, saline; TNF, tumor necrosis factor.
factor-5 (TGF-P) secreted by airway
epithelia and inflammatory cells may play a
role in the development of subepithelial
fibrosis. TGF-,B is a family ofseveral simi-
lar molecules (p1, P2, P3) whose genes are
highly conserved across species and are
thought to modulate the development of
fibrosis and other biologic processes (115).
TGF-P is abundant in the lung, can be
demonstrated in bronchoalveolar lavage
fluid, and appears to play an important role
in modulating inflammation in fibrotic
forms oflung disease. In vitro studies using
rat lung fibroblasts stimulated with
bleomycin indicate that increases in TGF-,
mRNA precede increases in mRNA for
procollagen I and procollagen III (116).
Among individuals with severe asthma,
TGF-P1 appears to localize in the submu-
cosa and is produced by macrophages,
eosinophils, and fibroblasts; the expression
ofTGF-,B1 was significantly associated with
subepithelial fibrosis and disease severity
(111). In aggregate, these findings indicate
that TGF- 1 is released beneath the base-
ment membrane and that TGF-,1 may
contribute to airway remodeling in
chronic asthma.
Natural History
The acute airway response to grain dust and
other organic dusts is predictive of the
chronic airway response to these agents.
This finding suggests that recurrent episodes
ofacute airway inflammation result in struc-
tural changes in the airway that lead to the
development and progression ofchronic air-
way disease. Several epidemiologic studies
have shown that the acute workshift-related
declines in airflow are independently associ-
ated with accelerated longitudinal declines
in lung function among grain handlers
(87,88,117), cotton workers (118-120),
and agricultural workers (40). Although
the workshift response to organic dust may
simply identify a cohort ofindividuals with
a high intrinsic risk of airway disease, it is
equally possible that the acute physiologic
and biologic responses to inhaled organic
dusts are involved in the pathogenesis of
progressive airway disease. This latter pos-
sibility is supported by findings from
studies in mice (121), rats (122), guinea
pigs (123-125), and hamsters (126) that
demonstrate that long-term inhalation of
grain or cotton dust can cause inflamma-
tory lesions in the airway lumen and
subepithelial region and hyperplasia ofthe
bronchiolar epithelia. In aggregate, find-
ings from human and animal studies indi-
cate that recurrent exposure to grain dust
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can lead to the development of chronic
airway disease.
Among patients with environmental
asthma, many continue to have asthma
despite removal from the exposure (127).
Remissions appear to be related to the
duration and intensity of the disease, with
earlier and less severe forms of asthma
more likely to improve. Spontaneous
recovery has not been reported among
workers who remain exposed to the agent
causing asthma (128,129). Thus, among
children in the rural setting, those with
asthma caused by specific exposures should
be encouraged to modify their exposures
by reducing the concentration of inhaled
dust and fumes.
Management
There is increasing evidence in patients
with asthma that control of the acute
inflammatory response substantially
improves airflow and chronic airway
inflammation (130-134). Because airway
inflammation is a major cause of airway
hyperresponsiveness in asthma (4,130,131,
135-139), control of the acute inflamma-
tory response should decrease the degree of
airway hyperresponsiveness. Inhaled
steroids (140-143) or prednisolone (144)
substantially improves airflow and airway
inflammation in asthma patients. Patients
with severe intrinsic asthma treated for 10
years with inhaled steroids demonstrated
reduced airway inflammatory cells and
restoration of ciliated epithelia ( 145).
These findings suggest that the persistent
inflammatory response in the airway lumen
is essential to the persistence of chronic
airway disease and that prolonged treat-
ment with anti-inflammatory medication is
indicated in most cases ofasthma.
Unique aspects of rural America
contribute to the morbidity associated with
any chronic disease and may necessitate
novel intervention strategies. Rural
Americans have inadequate access to health
care. Eight million rural Americans lack
health insurance, 26.5% of the rural unin-
sured are children, and 18% of all farm
families are uninsured (146). Among
asthma patients, the distance from an acute
care hospital is directly related to mortality
(147). Shortages of physicians and other
health care professionals, combined with a
shrinking number of rural hospitals (148),
have substantially impaired health care
delivery in rural communities. As a result,
children with asthma from rural (in com-
parison to urban) America face multiple
barriers that adversely affect their health:
more poverty, geographic barriers to health
care, less health insurance, and poorer
access to health care providers (13). Access
to and availability of high quality health
care must be considered when designing
intervention programs to reduce morbidity
and mortality associated with childhood
asthma in children from rural communi-
ties. For instance, because emergency trans-
port times may take up to 1 hr, it has been
suggested that in rural settings the emer-
gency medical services should be allowed
to administer more aggressive therapy
while enroute to the hospital (149).
Similarly, nurse-led home management
teams for asthma significantly reduce exac-
erbations and hospital admissions (150).
These systematic innovations, in combina-
tion with treatment with anti-inflamma-
tory medications and reduction ofexposure
to agricultural dusts, may substantially
reduce the morbidity ofasthma in children
from rural communities.
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